BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31468968)

  • 1. Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo.
    Tailor A; Waddington JC; Hamlett J; Maggs J; Kafu L; Farrell J; Dear GJ; Whitaker P; Naisbitt DJ; Park K; Meng X
    Chem Res Toxicol; 2019 Oct; 32(10):2095-2106. PubMed ID: 31468968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation.
    Callan HE; Jenkins RE; Maggs JL; Lavergne SN; Clarke SE; Naisbitt DJ; Park BK
    Chem Res Toxicol; 2009 May; 22(5):937-48. PubMed ID: 19358516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
    Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
    Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients.
    Meng X; Earnshaw CJ; Tailor A; Jenkins RE; Waddington JC; Whitaker P; French NS; Naisbitt DJ; Park BK
    Chem Res Toxicol; 2016 Oct; 29(10):1762-1772. PubMed ID: 27603302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
    Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
    Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
    Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.
    Naisbitt DJ; Farrell J; Gordon SF; Maggs JL; Burkhart C; Pichler WJ; Pirmohamed M; Park BK
    Mol Pharmacol; 2002 Sep; 62(3):628-37. PubMed ID: 12181439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
    Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
    Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
    Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
    J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals.
    Schnyder B; Burkhart C; Schnyder-Frutig K; von Greyerz S; Naisbitt DJ; Pirmohamed M; Park BK; Pichler WJ
    J Immunol; 2000 Jun; 164(12):6647-54. PubMed ID: 10843725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
    Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
    Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
    Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK
    Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.
    Jenkins RE; Yaseen FS; Monshi MM; Whitaker P; Meng X; Farrell J; Hamlett J; Sanderson JP; El-Ghaiesh S; Peckham D; Pirmohamed M; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2013 Jun; 26(6):963-75. PubMed ID: 23668298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
    Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
    Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase.
    Ogese MO; Jenkins RE; Maggs JL; Meng X; Whitaker P; Peckham D; Faulkner L; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2015 Jan; 28(1):144-54. PubMed ID: 25531135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
    Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.
    Elsheikh A; Lavergne SN; Castrejon JL; Farrell J; Wang H; Sathish J; Pichler WJ; Park BK; Naisbitt DJ
    J Immunol; 2010 Dec; 185(11):6448-60. PubMed ID: 20980635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.
    Naisbitt DJ; Gordon SF; Pirmohamed M; Burkhart C; Cribb AE; Pichler WJ; Park BK
    Br J Pharmacol; 2001 May; 133(2):295-305. PubMed ID: 11350866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulphonamide hypersensitivity: a naturally occurring model of idiosyncratic drug toxicity.
    Lavergne SN; Danhof RS; Volkman EM; Trepanier LA
    Clin Exp Allergy; 2006 Jul; 36(7):907-15. PubMed ID: 16839406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.